Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2016 August;64(4) > Minerva Cardioangiologica 2016 August;64(4):399-403

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints
Cite this article as

MINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,695


eTOC

 

EDITORIAL  NEW BIORESORBABLE TECHNOLOGY IN INTERVENTIONAL CARDIOLOGY


Minerva Cardioangiologica 2016 August;64(4):399-403

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Rationale for the use of bioresorbable vascular scaffolds. Why bioresorbable technology is the future of endovascular therapeutics

Flavio RIBICHINI

University of Verona, Verona, Italy


PDF  


top of page

Publication History

Cite this article as

Ribichini F. Rationale for the use of bioresorbable vascular scaffolds. Why bioresorbable technology is the future of endovascular therapeutics. Minerva Cardioangiol 2016 August;64(4):399-403. 

Corresponding author e-mail

flavio.ribichini@univr.it